Patriot Financial Group Insurance Agency’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-943
Closed -$125K 777
2022
Q2
$125K Buy
943
+2
+0.2% +$273 0.03% 487
2022
Q1
$129K Sell
941
-19
-2% -$2.65K 0.02% 512
2021
Q4
$166K Sell
960
-7
-0.7% -$1.06K 0.03% 505
2021
Q3
$140K Buy
967
+14
+1% +$2.05K 0.02% 546
2021
Q2
$126K Buy
953
+2
+0.2% +$262 0.02% 556
2021
Q1
$122K Buy
951
+23
+2% +$2.83K 0.03% 501
2020
Q4
$111K Buy
928
+2
+0.2% +$244 0.03% 474
2020
Q3
$106K Buy
926
+351
+61% +$41.5K 0.03% 374
2020
Q2
$66K Buy
+575
New +$61K 0.03% 444
2019
Q2
Sell
-8
Closed -$1K 1437
2019
Q1
$1K Hold
8
﹤0.01% 1091
2018
Q4
$1K Buy
+8
New +$750 ﹤0.01% 885

Other funds holding DGX

Patriot Financial Group Insurance Agency's DGX Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Quest Diagnostics (DGX) in Q3 2022, closing a stake of 943 shares — an estimated $125K sold.

Patriot Financial Group Insurance Agency first reported a position in DGX in Q4 2018 and held it in 11 quarters. The position peaked at $166K in Q4 2021. 809 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Quest Diagnostics position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 943 Quest Diagnostics shares in Q3 2022, an estimated $125K.
  • Patriot Financial Group Insurance Agency first reported a position in Quest Diagnostics in Q4 2018 and held it in 11 quarters.
  • Patriot Financial Group Insurance Agency's Quest Diagnostics position peaked at $166K in Q4 2021.
  • 809 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.